ArticleEuropean urology2020

Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma.

Min Yuen Teo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.